What's new Ip
TITLE
Japan’s IP High Court Awards $150 Million in Damages for Toray in REMITCH® Patent Infringement Case
DATE
Jun 23,2025
Japan’s IP High Court Awards $150 Million in Damages for Toray in REMITCH® Patent Infringement Case
On May 27, 2025, the Intellectual Property High Court of Japan delivered a landmark ruling in a patent infringement case involving patent term extension for the medical use patent related to the oral antipruritus medication REMITCH® (nalfurafine hydrochloride). The court awarded totaling approximately ¥21.76 billion (about $150 million USD) to Toray Industries from two major generic drug manufacturers: Sawai Pharmaceutical Co., Ltd., and Fuso Pharmaceutical Industries, Ltd., setting a historical record for damages granted in a patent infringement case in Japan.
An appeal to the Supreme Court is currently pending.
2025
-
Jul 7,2025The IP High Court Releases Recent IP Litigation Statistics in Japan.
-
Jun 23,2025Japan’s IP High Court Awards $150 Million in Damages for Toray in REMITCH® Patent Infringement Case
-
Jun 12,2025If you have Multi-Multi Dependency in Claims Now
-
May 12,2025JPAA launches AI guideline for patent attorneys
-
Apr 22,2025First Trademark Registration using the Consent System in Japan
-
Apr 14,2025Is It Possible to Draft Patent Specifications Using Generative AI?
-
Mar 31,2025Japan Patent Office published JPO Status Report 2025
-
Mar 5,2025Japan Patent Office’s Information Provision System (Third-Party Observation)
-
Feb 7,2025Status survey of AI-related applications by JPO
-
Jan 22,2025Advancements in Trademark Examination Using AI by the Japan Patent Office (JPO)
-
Jan 14,2025The Patent Prosecution Highway (PPH) pilot program between the Japan Patent Office (JPO) and the National Institute of Industrial Property of France (INPI)
2024
-
Dec 23,2024JPO to Review Patent and Design Acts Amid Generative AI Expansion
-
Dec 6,2024Recent Application Trends In Business-Related Inventions
-
Oct 15,2024Trademark Registration for “Sound” in Japan
-
Sep 24,2024System Reform to Promote the Use of Generic Drugs
-
Sep 9,2024Surge in Insider Data Breaches
-
Aug 26,2024JPO published the Annual Report 2024
-
Aug 15,2024Non-disclosure of Patent Applications in Japan
-
Jul 16,2024Trend of examination of AI core-technology inventions is now very patent applicant-friendly in Japan
-
Jul 5,2024Kluwer Patent Blog / Japan’s first case regarding compulsory license based on public interest is finally settled
-
Jul 1,2024Digital Issuance of Registration Certificates at the Japan Patent Office
-
Jun 17,2024The JPO engaged external AI advisors for supporting patent examiners in April 2024
-
Jan 9,2024Kluwer Patent Blog / Japan: Sawai’s Generic Drug is approved by the MHLW amid patent litigation with Bristol-Myers Squibb, but the Court orders preliminary injunction against Sawai soon after
2023
-
Dec 5,2023Trademark Protection for Single Color in Japan
-
Nov 15,2023Preliminary Statistical Data on Patent Applications, etc. (data for August 2023)
-
Sep 25,2023Japanese IP Law Revisions of 2023
-
Sep 8,2023VC collaborating on IP Acceleration program for Startups (VC-IPAS)
-
Sep 5,2023JAPP Organizes Issues on Copyright with Generative AI
-
Aug 18,2023The Japanese Government’s Approach to legal issues in Metaverse
-
Aug 15,20232023 ANNUAL REPORT from JAPAN PATENT OFFICE
-
Aug 7,2023SECRET PATENT APPLICATION SYSTEM WILL COME INTO EFFECT IN SPRING 2024
-
Jul 31,2023The JPO interviewed an inventor of an electronics geek!
-
Jul 4,2023The IP High Court Releases Recent IP Litigation Statistics in Japan
-
Jun 26,2023Industrial Design Protection for “Graphic Images” in Japan
-
Jun 5,2023Status of Applications filed after Restriction on Multi-Multi Claims
-
May 29,2023Termination of simplified procedure for remedy from expiration of time limits in case of Covid 19
-
May 19,2023Law revision for strengthening the prohibition of design imitation in the metaverse
-
May 15,2023Kluwer Patent Blog / Amgen v. Sanofi and Regeneron: Japan IP High Court overrules its own decision on validity of Amgen patent
-
Apr 10,2023Japan changes from “Two-Step” to “Lump-Sum” payment of individual fees for International Trademark Registrations
-
Apr 5,2023Award Ceremony held for Patent Contest and Design Patent Contest
-
Mar 31,2023Status of Suspension on Intellectual Property Infringing Goods at Customs in 2022
-
Mar 28,2023New Japan IP High Court Grand Panel Case regarding Territorial Principal Issue
-
Mar 8,2023Japan Patent Office provides service of Patent Examination Initiation Expected Time Inquiry
-
Mar 6,2023JPO Announces Application Trends for Newly Protected Designs under the Revised Design Act
-
Feb 27,2023New system to suspend examination for divisional patent applications
-
Feb 22,2023Relaxation of requirements for reinstatement of rights such as patent rights 【Patent・Utility・Design・Trademark】
-
Feb 9,2023Tokyo District Court Awards Extraterritorial Damages for Domestic Patent Infringement
-
Jan 30,2023Update on discussions for improving the Japanese Trademark System
-
Jan 16,2023New Year Greetings from JPO Commissioner
2022
-
Dec 22,2022Recent Trends in the Number of Business-related Invention Applications
-
Dec 16,2022Japanese First Official Amicus Brief Case
-
Dec 12,2022Kluwer Patent Blog / Japan IP High Court’s first-ever decision allowing patent enforcement against infringing acts partially committed outside of Japan
-
Nov 28,2022Collaboration with WIPO GREEN
-
Nov 22,2022Increasing number of trademark applications for use in metaverse and tips for overcoming JPO objections
-
Nov 15,2022US-JP Collaborative Search Pilot (CSP) to be continued until October 31, 2024
-
Nov 8,2022Japan IP High Court’s Grand Panel Decision Granted Reasonable Royalty to a Part Where the Presumption of Damages was Overturned
-
Oct 25,2022A Copy of the Power of Attorney Can Now Be Filed
-
Oct 18,2022JPO released Analysis Results of the US-JP Collaborative Search Pilot Program Phase 2
-
Oct 11,2022Status of Applications filed after the restriction of Multi-Multi Claims
-
Oct 4,2022Japan IP High Court’s First-Ever Decision Allowing Extraterritorial Application of Japanese Patent Rights
-
Sep 30,2022Kluwer Patent Blog / Japan: Guidelines for a Transparent and Predictable SEP Licensing Negotiation
-
Sep 20,2022Business Court will celebrate its grand opening in October 2022
-
Sep 7,2022JPO updated Quality Management Manual for Patent Examination
-
Aug 1,2022Number of IP related applications in Japan
-
Jul 27,2022Updated Statistics of Intellectual Property Cases in Japan
-
Jul 19,2022Green Transformation Technologies Inventory (GXTI) published
-
Jul 6,2022The Japan Patent Office (JPO) published a report on several topics that were discussed by a study group convened by the JPO for improving the Japanese Intellectual Property system
-
Jun 27,2022Action Plan for the Utilization of Artificial Intelligence (AI) Technology
-
Jun 20,2022Emergency approval under Pharmaceutical and Medical Device Act
-
Jun 13,2022No more Multi-Multi Claims in Japan